BIOACTIVES

Bioactives are naturally occurring components that are known to affect and modulate a wide range of enzymatic routes, contributing significantly to health when they are consumed throughout life as part of the daily diet

LEARN MORE

NEWS 2016

Gnosis’ Report unveils High Stability of vitaMK7®: natural IS MORE stable

Gnosis vitaMK7® is produced through a unique and innovative industrialization method to deliver natural, stable, high purity (>99% pure) Vitamin K2 as MK7 from fermentation, in order to resemble the natural occurring Vitamin K2 present in the Japanese natto food. [...]

LEARN MORE

A new achievement by Gnosis and our MKT team

Gnosis is proud to announce that from now on our tools are also available in other two different languages: Chinese and Russian. [...]

LEARN MORE

The 24th Annual World Congress on Anti-Aging Medicine

From December 9th to 11th, for the first time Gnosis will exhibit at the American Academy of Anti-Aging Medicine Congress with Quatrefolic, VitaMK7, Adomet and Biooptima. [...]

LEARN MORE

Gnosis listed in the Certified Companies of Halal International Authority (HIA)

We are proud to inform our partners and customers that both of ours Manufacturing Operations - Gnosis Bioresearch SA (Sant'Antonino - CH) and Gnosis Bioresearch Srl (Pisticci – Italy) - have been listed in the Certified Companies of Halal International Authority (HIA), the independent organization which since 2010 has become the Halal Certification Authority recognized on an international scale. [...]

LEARN MORE

Vitamin K2 stands in the front rank for nutrients at World Osteoporosis Day

On the occasion of the World Osteoporosis Day which takes place every year on October 20th, Gnosis has participated at the special event "Supplements in the non-pharmacologic treatment of osteoporosis" with a speech held by Dr. Luca Tiano [...]

LEARN MORE

Enthusiastic feed-back of nutraceutical industry at VENDORBRIEF speech on Mythocondro®

In the last weeks, a great curiosity and an expectable enthusiasm have been felt about the speech organized by Gnosis in the Education Session of the VENDORBRIEF Presentation at Supply Side West, on the new non-animal chondroitin sulfate branded Mythocondro®. [...]

LEARN MORE

Overwhelming success of Gnosis at Supply Side West and CPhI

Overwhelming success of Gnosis in October which took part at two key and concurrent events, the CPhI - the leading European pharmaceutical exhibition held in Barcelona - and the SupplySide West - one of the world's leading ingredient and solutions tradeshow of nutraceutical industry, held in Las Vegas. [...]

LEARN MORE

Gnosis welcomes you at CPhI 2016, "The Worldwide Pharma Exhibition"

Gnosis will be exhibiting at CPhI Worldwide, which will be held in Barcelona from 4th to 6th October. CPhI is the leading European pharmaceutical exhibition, the core meeting point of the global pharmaceutical community where to discuss business opportunities and stay tuned on market news and trends. [...]

LEARN MORE

Mythocondro® Vendorbrief Presentation at Supply Side West

Supply Side West is approaching and we will be protagonist with the launch of Mythocondro®, the first Non-Animal Chondroitin sulfate of fermentation origin, that promises to change completely the CS industry. [...]

LEARN MORE

Gnosis... an Italian player in the global healthcare market

Read about Gnosis in the report "Italy Healthcare and Life Sciences Review 2016" that will provide an updated and thorough insight into the Italian Healthcare & Pharmaceutical sector. [...]

LEARN MORE

MK7 Standards Reference: a brand-new section for vitaMK7® website

The high success of Vitamin K2 menaquinone-7 in several markets, and the recognition of tangible benefits of its supplementation, stated the matter of recognized common standards of the ingredient both from manufacturer of finished products and end-users [...]

LEARN MORE

XaQuilXR with Quatrefolic® is the Finished Product of the Year

Gnosis is proud to announce that its commitment to providing innovative solutions to global well-being and health care challenges has been rewarded at NutraIngredients Award 2016, winning in the FINISHED PRODUCT OF THE YEAR - medical food category [...]

LEARN MORE

Welcome to the brand-new Quatrefolic® website!

2016 sees Quatrefolic® keep collecting achievements, establishing itself in the entire global market as the benchmark for the whole industry of folate derivatives [...]

LEARN MORE

Vitafoods time! Gnosis more and more in the limelight

The global nutraceutical event is growing each time and this year is no exception. The nutraceutical business meets in Geneva on May 10th through 12th [...]

LEARN MORE

Gnosis vitaMK7® earns Novel Food Approval in Brazil by ANVISA

Gnosis is delighted to announce that on February 22nd, 2016 the Brazilian National Health Surveillance Agency, ANVISA, has approved the use of vitaMK7® [...]

LEARN MORE

Gnosis exhibits at “Integrative Healthcare symposium conference”: is this a new concept of “Innovative nutraceutical supplier”?

Recent startling progress in life science research herald new developments in food, nutrition and health and are, today as in the past, the stimulus to Gnosis to create the wide range of products [...]

LEARN MORE

The first 2016 issue of vitaMK7® Pulse newsletter has been released!

This first issue is focused on the possibility to assume the right amount of Vitamin K2, either by supplements and functional food. [...]

LEARN MORE

A 2016 newborn: Gnosis' Advanced Information Newsletter!

A brand-new newsletter has been released by Gnosis! Advanced Information Newsletter is our commitment to increase Gnosis-to-customer communication [...]

LEARN MORE

VitaMK7® new Chinese website release is now out!

Gnosis is proud to announce the release of a new vitaMK7® - Chinese version - website, which goes live today [...]

LEARN MORE

The brand-new section is now online!

VitaMK7® website is more interesting than ever! If you are craving for information about vitamin K2, you must go online on vitaMK7® website and take a look [...]

LEARN MORE

Back to news


By using our website you are consenting to our use of cookies in accordance with our Cookie Policy.

Close